Javascript must be enabled to continue!
The cost of health care for children and adults with sickle cell disease
View through CrossRef
AbstractAlthough sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown. The purpose of this study was to estimate the total cost of medical care for a population of children and adults with SCD. We used data from individuals diagnosed with SCD enrolled in the Florida Medicaid program during 2001–2005 to estimate total, SCD‐related, and non‐SCD‐related cost per patient‐month based on patient age at the time of health care use. Across the 4,294 patient samples, total health care costs generally rose with age, from $892 to $2,562 per patient‐month in the 0–9‐ and 50–64‐year age groups, respectively. Average cost per patient‐month was $1,389. Overall, 51.8% of care was directly related to SCD, the majority of which (80.5%) was associated with inpatient hospitalizations. Notably, non‐SCD‐related costs were substantially higher than those reported for the general US population. These results suggest a discounted (3% discount rate) lifetime cost of care averaging $460,151 per patient with SCD. Interventions designed to prevent SCD complications and avoid hospitalizations may reduce the significant economic burden of the disease. Am. J. Hematol. 2009. © 2009 Wiley‐Liss, Inc.
Title: The cost of health care for children and adults with sickle cell disease
Description:
AbstractAlthough sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown.
The purpose of this study was to estimate the total cost of medical care for a population of children and adults with SCD.
We used data from individuals diagnosed with SCD enrolled in the Florida Medicaid program during 2001–2005 to estimate total, SCD‐related, and non‐SCD‐related cost per patient‐month based on patient age at the time of health care use.
Across the 4,294 patient samples, total health care costs generally rose with age, from $892 to $2,562 per patient‐month in the 0–9‐ and 50–64‐year age groups, respectively.
Average cost per patient‐month was $1,389.
Overall, 51.
8% of care was directly related to SCD, the majority of which (80.
5%) was associated with inpatient hospitalizations.
Notably, non‐SCD‐related costs were substantially higher than those reported for the general US population.
These results suggest a discounted (3% discount rate) lifetime cost of care averaging $460,151 per patient with SCD.
Interventions designed to prevent SCD complications and avoid hospitalizations may reduce the significant economic burden of the disease.
Am.
J.
Hematol.
2009.
© 2009 Wiley‐Liss, Inc.
Related Results
Adverse pregnancy, fetal and neonatal outcomes in women with sickle cell disease in a Middle Eastern country
Adverse pregnancy, fetal and neonatal outcomes in women with sickle cell disease in a Middle Eastern country
Background: Sickle cell disease in pregnancy is associated with high maternal and fetal mortality. However, studies reporting pregnancy, fetal, and neonatal outcomes in women with ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Selected Testing of Newborns for Sickle Cell Disease
Selected Testing of Newborns for Sickle Cell Disease
There are two main reasons for sickle cell testing: the early detection of those with sickle cell disease and the detection of the carrier state, sickle cell trait. The mortality o...
Lapse kuvandist täiskasvanute ja laste endi pilgu läbi
Lapse kuvandist täiskasvanute ja laste endi pilgu läbi
The article analyses the image of the child as perceived from the perspective of children and adults and determines to what extent the perceptions vary between the children and adu...
Exchange Transfusion In Adult Patients With Sickle Cell Disease With Refractory Vaso-Occlusive Crises
Exchange Transfusion In Adult Patients With Sickle Cell Disease With Refractory Vaso-Occlusive Crises
Sickle cell disease occurs in 1/500 African-American births. Pain is one of the most common complications of sickle cell disease and is associated with depression, anxiety, decreas...
Family Pediatrics
Family Pediatrics
ABSTRACT/EXECUTIVE SUMMARYWhy a Task Force on the Family?The practice of pediatrics is unique among medical specialties in many ways, among which is the nearly certain presence of ...
Intermittent Fasting in Sickle Cell Disease: Case series and Review of Literature
Intermittent Fasting in Sickle Cell Disease: Case series and Review of Literature
Abstract
Presentation Date: 6/8/2024
Presentation Start Time: 6:00:00 PM
...
Sickle Cell Disease and Uterine Fibroids: Evaluation of the Prevalence of Fibroids across Sickle Cell Genotypes
Sickle Cell Disease and Uterine Fibroids: Evaluation of the Prevalence of Fibroids across Sickle Cell Genotypes
ABSTRACT
Introduction
Uterine fibroids are known to affect >80% of premenopausal American women of African descent, and sick...

